Hanmi Pharm. Co., Ltd. (128940.KS)
128940.KS Stock Price Chart
Explore Hanmi Pharm. Co., Ltd. interactive price chart. Choose custom timeframes to analyze 128940.KS price movements and trends.
128940.KS Company Profile
Discover essential business fundamentals and corporate details for Hanmi Pharm. Co., Ltd. (128940.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
30 Jul 2010
Employees
2.27K
Website
https://www.hanmipharm.comCEO
Jae-Hyun Park
Description
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
128940.KS Financial Timeline
Browse a chronological timeline of Hanmi Pharm. Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 24 Oct 2025
Revenue estimate is ₩395.68B.
Earnings released on 25 Jul 2025
EPS came in at ₩2.88K , while revenue for the quarter reached ₩361.28B , missing expectations by -8.43%.
Dividend declared on 27 Jun 2025
A dividend of ₩250.00 per share was announced, adjusted to ₩250.00. The dividend was paid on 14 Aug 2025.
Earnings released on 28 Apr 2025
EPS came in at ₩3.36K falling short of the estimated ₩4.28K by -21.43%, while revenue for the quarter reached ₩390.95B , missing expectations by -1.47%.
Earnings released on 1 Feb 2025
EPS came in at -₩390.73 falling short of the estimated ₩2.01K by -119.48%, while revenue for the quarter reached ₩351.61B , missing expectations by -18.98%.
Dividend declared on 27 Dec 2024
A dividend of ₩1.00K per share was announced, adjusted to ₩1.00K. The dividend was paid on 14 Apr 2025.
Earnings released on 31 Oct 2024
EPS came in at ₩2.45K falling short of the estimated ₩3.04K by -19.57%, while revenue for the quarter reached ₩362.08B , missing expectations by -2.93%.
Earnings released on 30 Jul 2024
EPS came in at ₩3.18K surpassing the estimated ₩2.46K by +29.23%, while revenue for the quarter reached ₩378.13B , missing expectations by -0.68%.
Dividend declared on 27 Jun 2024
A dividend of ₩250.00 per share was announced, adjusted to ₩250.00. The dividend was paid on 14 Aug 2024.
Earnings released on 30 Apr 2024
EPS came in at ₩4.34K surpassing the estimated ₩3.61K by +20.10%, while revenue for the quarter reached ₩403.68B , beating expectations by +1.24%.
Earnings released on 2 Feb 2024
EPS came in at ₩2.76K surpassing the estimated ₩2.56K by +7.98%, while revenue for the quarter reached ₩422.35B , beating expectations by +5.37%.
Dividend declared on 27 Dec 2023
A dividend of ₩500.00 per share was announced, adjusted to ₩500.00. The dividend was paid on 12 Apr 2024.
Stock split effective on 27 Dec 2023
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Nov 2023
EPS came in at ₩4.40K surpassing the estimated ₩2.79K by +57.67%, while revenue for the quarter reached ₩364.61B , missing expectations by -0.96%.
Earnings released on 28 Jul 2023
EPS came in at ₩1.12K falling short of the estimated ₩1.73K by -35.19%, while revenue for the quarter reached ₩342.73B , missing expectations by -0.33%.
Earnings released on 26 Apr 2023
EPS came in at ₩3.47K surpassing the estimated ₩2.54K by +36.55%, while revenue for the quarter reached ₩361.19B , missing expectations by -0.44%.
Earnings released on 8 Feb 2023
EPS came in at ₩1.56K falling short of the estimated ₩1.76K by -11.11%, while revenue for the quarter reached ₩351.17B , missing expectations by -2.97%.
Dividend declared on 28 Dec 2022
A dividend of ₩500.00 per share was announced, adjusted to ₩490.20. The dividend was paid on 5 Apr 2023.
Stock split effective on 28 Dec 2022
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Nov 2022
EPS came in at ₩2.04K surpassing the estimated ₩1.69K by +20.39%, while revenue for the quarter reached ₩342.15B , beating expectations by +4.01%.
Earnings released on 18 Jul 2022
EPS came in at ₩1.48K surpassing the estimated ₩953.17 by +55.21%, while revenue for the quarter reached ₩317.10B , beating expectations by +0.48%.
Earnings released on 16 May 2022
EPS came in at ₩1.57K falling short of the estimated ₩1.73K by -9.39%, while revenue for the quarter reached ₩321.13B , beating expectations by +4.41%.
Earnings released on 27 Jan 2022
EPS came in at ₩1.40K surpassing the estimated ₩1.24K by +13.28%, while revenue for the quarter reached ₩350.48B , beating expectations by +1.40%.
Dividend declared on 29 Dec 2021
A dividend of ₩500.00 per share was announced, adjusted to ₩480.58. The dividend was paid on 5 Apr 2022.
Stock split effective on 29 Dec 2021
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 4 Nov 2021
EPS came in at ₩1.88K surpassing the estimated ₩1.21K by +55.25%, while revenue for the quarter reached ₩303.08B .
Earnings released on 29 Jul 2021
EPS came in at ₩569.97 falling short of the estimated ₩1.23K by -53.76%, while revenue for the quarter reached ₩279.31B .
Earnings released on 17 May 2021
EPS came in at ₩1.53K surpassing the estimated ₩1.51K by +1.45%, while revenue for the quarter reached ₩270.32B .
Earnings released on 4 Feb 2021
EPS came in at ₩2.25K surpassing the estimated ₩778.82 by +189.03%, while revenue for the quarter reached ₩277.31B .
Dividend declared on 29 Dec 2020
A dividend of ₩500.00 per share was announced, adjusted to ₩471.16. The dividend was paid on 2 Apr 2021.
Stock split effective on 29 Dec 2020
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Oct 2020
EPS came in at -₩2.52K falling short of the estimated ₩1.03K by -345.43%, while revenue for the quarter reached ₩266.93B .
128940.KS Stock Performance
Access detailed 128940.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.